Related Experiment Videos
The Campylobacter pylori story
1Division of Gastroenterology, University of Virginia, Charlottesville 22908.
Abstract:
The Campylobacter pylori story began before the turn of the century, with early works describing 'spirochaetes' in the gastric mucosa of animals. Culture of the organism in 1982 enabled investigators to make sense of the many previous works concerning the microbiology, biochemistry, and histology of the gastric mucosa. Whereas some physicians remain skeptical of C. pylori's pathogenic role, those who have studied the new organism believe it is a major gastrointestinal pathogen and see the possibility of curative therapy for what is now called 'acid peptic disease'.
Insights
The discovery of Campylobacter pylori, a bacterium in stomach lining, revolutionized understanding of gastric diseases. This finding offers potential for new treatments for acid peptic disease.
Area of Science:
- Gastroenterology
- Microbiology
- Pathogenesis
Background:
- Early research noted spiral bacteria in animal gastric mucosa before the 20th century.
- The isolation and culture of Campylobacter pylori in 1982 provided a key to understanding previous gastric mucosa studies.
Observation:
- Campylobacter pylori, a newly identified organism, was observed in the gastric mucosa.
- The organism's microbiology, biochemistry, and histology were investigated.
Findings:
- Despite some skepticism, researchers believe Campylobacter pylori is a significant gastrointestinal pathogen.
- The successful culture of the organism clarified its role in gastric conditions.
Implications:
- The identification of Campylobacter pylori opens avenues for curative therapies for acid peptic disease.
- This discovery challenges previous understandings of gastric health and disease etiology.